Market Research Logo

Kazakhstan Pharmaceuticals and Healthcare Report Q2 2015


Attention: There is an updated edition available for this report.

Kazakhstan Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Within the pharmaceutical sector, the Kazakh government is looking to reduce its importreliance and also to serve its growing healthcare needs. In light of the Kazakh government's commitment toramping up healthcare expenditure and incentivising foreign investment, we believe multinationalcompanies will localise manufacturing to a limited extent. Given the logistical challenges, limited skilledlabour and a lack of necessary infrastructure, we expect that investment in local production will primarilyoccur through larger companies.

Headline Expenditure Projections

Pharmaceuticals: KZT335.18bn (USD1.87bn) in 2014 to KZT395.60bn (USD2.04bn) in 2015; +18.0%in local currency terms and +9.4% in US dollar terms.

Healthcare: KZT1,740.14bn (USD9.70bn) in 2014 to KZT2,027.16bn (USD10.47bn) in 2015; +16.5%in local currency terms and +8.0% in US dollar terms.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kazakhstan 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2011-2019)
Prescription Drug Market
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kazakhstan 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Kazakhstan 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Kazakhstan 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Table: GDP By Expenditure (Kazakhstan 2011-2018)
Industry Risk Reward Ratings
Central And Eastern Europe Risk/Reward Index
Kazakhstan Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Healthcare Sector Financing
Domestic Pharmaceutical Industry
Wholesale And Retail
Foreign Pharmaceutical Industry
Clinical Trials
Regulatory Development
Intellectual Property Environment
Pricing And Reimbursement Regime
Competitive Landscape
Company Profile
Chimpharm
Romat
Novartis
Sanofi
GlaxoSmithKline
Nycomed
Merck & Co.
Pfizer
Ranbaxy
Demographic Forecast
Table: Population Headline Indicators (Kazakhstan 1990-2025)
Table: Key Population Ratios (Kazakhstan 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Kazakhstan 1990-2025)
Table: Population By Age Group (Kazakhstan 1990-2025)
Table: Population By Age Group % (Kazakhstan 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report